$9 Billion Deal!

Stocks
rose Monday in the best Dow rally in over two weeks,

with 28 Dow components in plus territory.
Strong ISM numbers started the day off: 
61.4, and the first time the index has remained at this level since 1983. This
is the ninth consecutive month of growth.

The Nikkei gained 2.5%, breaking the 11,250 level.
JP Morgan downgraded Intel
(
INTC |
Quote |
Chart |
News |
PowerRating)

ahead of its mid-quarter update to neutral citing concerns over INTC’s notebook
sales and leveling off of sales as a whole. The Semiconductor Industry
Association forecasts a 19.4% worldwide sales growth in chips for 2004 and said
sales were up 27% year over year. JPM also downgraded AMD
(
AMD |
Quote |
Chart |
News |
PowerRating)
, as
it predicted pricing pressure from Intel over its flash memory products.

Commodities such as aluminum,
lumber, and copper, silver continue to make multi-year highs. Companies
benefiting from this boom include Phelps Dodge
(
PD |
Quote |
Chart |
News |
PowerRating)
, Alcoa,
(
AA |
Quote |
Chart |
News |
PowerRating)

and U.S. Steel
(
X |
Quote |
Chart |
News |
PowerRating)
. Maytag
(
MYG |
Quote |
Chart |
News |
PowerRating)
, a major steel buyer, is
cutting costs to offset higher steel prices.  Coal stocks were also strong
after a Barron’s article over the weekend. Platinum hit a 24-year high.

The FDA is willing to approve Sepracor’s
(
SEPR |
Quote |
Chart |
News |
PowerRating)
sleeping pill if
certain conditions are met. The FDA didn’t ask for more patient testing info
which will allow SEPR to save a significant amount of time and money. SEPR is up
45% today.

Homebuilders continue to be strong, with most stocks at 52-week highs or
all-time highs. Furniture Brands
(
FBN |
Quote |
Chart |
News |
PowerRating)
raised its forecast and made a
52-week high. Hovnanian
(
HOV |
Quote |
Chart |
News |
PowerRating)
was inline for Q1, and raised guidance
to $9.50 for ’04.

The world’s largest miner,
BHP Billiton

(
BHP |
Quote |
Chart |
News |
PowerRating)
signed a agreement with four Chinese steel companies
to provide 12 million tons of iron ore per year for the next 25 years. The deal
is worth $9 billion. BHP is based in London and its ADRs trade in the US.

Citigroup
(
C |
Quote |
Chart |
News |
PowerRating)
said it
received a subpoena tied to its mutual fund practices.

SG Cowan is getting rid
of their stock ratings system, saying it is too rigid and puts companies in
pre-defined categories. They will now use plain English in their reports. The
company is also abolishing their earnings post-mortems but said it is not
dropping coverage on any stocks.

Closing arguments began in the
Martha Stewart trial.

Dow 
+94.22

10678.14
S&P 500

+11.03

1155.97
Nasdaq
+27.98

2057.80

The day’s leading sectors were
Homebuilders
(
HGX.X |
Quote |
Chart |
News |
PowerRating)
+2.98%, Oil Services
(
OSX.X |
Quote |
Chart |
News |
PowerRating)

+2.80%, Energy
(
DXE.X |
Quote |
Chart |
News |
PowerRating)
+2.31%, and Airlines
(
XAL.X |
Quote |
Chart |
News |
PowerRating)

+2.87%. 

Weak today were Biotechs
(
BTK.X |
Quote |
Chart |
News |
PowerRating)
-0.07%.

Economic news releases included
lower personal income at 0.2%, with a 0.1% increase in personal spending at
0.4%. Construction spending fell by 0.3% and the ISM index lower at 61.4.

10-year Notes were -025
at 115 095

Dollar was +0.22 at
87.53

Gold was +0.69 at 398.82

Crude Oil  was +0.69 at
36.86

Volume was
1,455,034,000
on the NYSE, and
1,681,144,000
on the Nasdaq.

Market breadth was positive.

NYSE  Issues  
Advancing  2509 Up Vol       1126
Declining 797 Down Vol   253
Ratio  3.14 4.45
Nasdaq     
Advancing  2168 Up Vol      1324
Declining  1062 Dow Vol    329
Ratio  2.04 4.02

Stocks in the news:

Cytyc
(
CYTC |
Quote |
Chart |
News |
PowerRating)
announced a deal to
purchase Novacept, a maker of menorrhagia treatment system for $325 million in
cash.  The deal is expected to result in a one-time $20 million charge and
positively affect the company in 2005. CYTC is up 14% on the news.

Impax
(
IPXL |
Quote |
Chart |
News |
PowerRating)
received tentative
approval from the FDA to sell its generic version of allergy medicine Allegra-D
pending results of the Aventis
(
AVE |
Quote |
Chart |
News |
PowerRating)
lawsuit over patent
infringement.

Universal Health Services
(
UHS |
Quote |
Chart |
News |
PowerRating)

said its first-quarter earnings may be 25% lower than a year ago due to weak
patient admissions and a rising debt expense from uninsured patients. UHS had an
EPS of 84 cents the same period a year go.UHS closed at 44.88, down 9.05.

Brice Wightman